The FDA approved the investigational new drug application for a phase 1 trial of ADCE-T02 in advanced solid tumors.

Childhood neuroblastoma is often a fatal disease. A new approach using a combination of two drugs shows promise in reducing ...

Adcendo, a biotech company pioneering the development of first and best-in-class ADCs for cancers with a high unmet medical ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal growth factor receptor 2 (HER2) biparatopic antibody-drug conjugate (ADC), ...

Topoisomerase 2β (TOP2B) introduces transient double strand breaks in the DNA helix to remove supercoiling structures and unwind entangled DNA strains. Advances in genomic technologies have enabled ...

Get Instant Summarized Text (Gist) The FDA has approved Datroway (datopotamab deruxtecan-dlnk) for adults with unresectable or metastatic HR-positive, HER2-negative breast cancer after progression ...